MORGAN STANLEY - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$20,249,769
-36.3%
981,569
-8.9%
0.00%
-33.3%
Q2 2023$31,778,906
+142.4%
1,076,886
+89.2%
0.00%
+200.0%
Q1 2023$13,112,570
+9.0%
569,122
+31.6%
0.00%0.0%
Q4 2022$12,027,435
-42.5%
432,486
-36.5%
0.00%
-66.7%
Q3 2022$20,909,000
+68.0%
681,332
+61.1%
0.00%
+50.0%
Q2 2022$12,449,000
-45.2%
423,011
-40.1%
0.00%
-33.3%
Q1 2022$22,702,000
+77.2%
705,655
+145.7%
0.00%
+50.0%
Q4 2021$12,812,000
-33.9%
287,258
-25.2%
0.00%
-33.3%
Q3 2021$19,373,000
-42.7%
383,993
-10.9%
0.00%
-25.0%
Q2 2021$33,810,000
+28.1%
431,032
-6.7%
0.00%0.0%
Q1 2021$26,389,000
+43.6%
462,160
+110.6%
0.00%
+33.3%
Q4 2020$18,378,000
+68.3%
219,428
-28.0%
0.00%
+50.0%
Q3 2020$10,923,000
+41.7%
304,860
-4.4%
0.00%0.0%
Q2 2020$7,711,000
+183.3%
318,927
+105.2%
0.00%
+100.0%
Q1 2020$2,722,000
-37.2%
155,422
-37.5%
0.00%0.0%
Q4 2019$4,335,000
+73.5%
248,809
+52.5%
0.00%0.0%
Q3 2019$2,498,000
-17.6%
163,100
+11.7%
0.00%0.0%
Q2 2019$3,032,000
-1.0%
146,075
+10.8%
0.00%0.0%
Q1 2019$3,062,000
-27.4%
131,892
-35.4%
0.00%0.0%
Q4 2018$4,219,000
+3.8%
204,214
+9.3%
0.00%0.0%
Q3 2018$4,063,000
+126.5%
186,902
+58.9%
0.00%
Q2 2018$1,794,000
+10.8%
117,636
+43.1%
0.00%
Q1 2018$1,619,000
+5896.3%
82,209
+4846.4%
0.00%
Q4 2017$27,0001,6620.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders